Can dextrose‑water (DW) be infused through a peripheral intravenous line?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Dextrose-Water Be Infused Through a Peripheral IV?

Yes, dextrose solutions can be infused through peripheral IVs, but only if the osmolarity does not exceed 850 mOsm/L and the concentration is appropriate for peripheral administration. Higher concentrations (>10% dextrose) should generally be avoided in peripheral lines due to significant risk of thrombophlebitis and tissue necrosis if extravasation occurs.

Osmolarity Limits for Peripheral Administration

The most critical factor is osmolarity. Peripheral insertion is inappropriate for infusion of fluid with high osmolarity (>500 mOsm/L) according to the Association of Anaesthetists guidelines 1. However, ESPEN guidelines for parenteral nutrition are slightly more permissive, stating that peripheral PN should only use nutrient solutions whose osmolarity does not exceed 850 mOsm/L 2.

Common Dextrose Solutions and Their Osmolarity:

  • D5W (5% dextrose): ~252 mOsm/L - Safe for peripheral use
  • D10W (10% dextrose): ~505 mOsm/L - Borderline/use with caution
  • D25W (25% dextrose): ~1,262 mOsm/L - Requires central access
  • D50W (50% dextrose): ~2,525 mOsm/L - Requires central access

Concentration-Specific Considerations

D5W and D10W (Safe for Peripheral Use)

  • D5W is routinely used peripherally for maintenance fluids and medication dilution
  • D10W can be used peripherally but requires closer monitoring for phlebitis
  • Research shows D10W is effective and safe when used appropriately 3
  • Pediatric guidelines support D10W for maintenance fluids in children 4

D25W and D50W (Central Access Required)

D50W is irritating to veins; dilution to 25% dextrose is desirable 5. Even with dilution, these concentrations should ideally go through central access. Research from 1975 documented that peripheral extravasation of intravenous solutions containing 10% dextrose has caused significant local tissue necrosis in multiple patients, including severe disfigurement 6.

Risk Mitigation Strategies

When using dextrose solutions peripherally, implement these protective measures 2:

  • Choose the smallest gauge catheter possible (ideally catheter diameter should be one-third or less of vein diameter)
  • Use polyurethane or silicone catheters rather than Teflon
  • Ensure pH is between 5 and 9
  • Adequate catheter fixation with transparent adhesive membranes
  • Careful surveillance for thrombophlebitis - this is mandatory for all peripheral dextrose infusions
  • Consider adding lipid emulsion to parenteral nutrition solutions, as research shows this may have a protective effect on vein walls and prolongs catheter life 7

When Central Access Is Required

Central venous access is needed when 2:

  • Dextrose concentration exceeds 10%
  • Osmolarity exceeds 850 mOsm/L
  • Parenteral nutrition is required for >2 weeks
  • The solution contains other hyperosmolar components (high amino acid concentrations, certain electrolytes)

Common Pitfalls to Avoid

  1. Don't assume all "dextrose-water" is the same - concentration matters critically
  2. Don't use D50W peripherally - the 1975 case series showed devastating tissue necrosis from extravasation 6
  3. Don't ignore early signs of phlebitis - pain, erythema, or swelling mandate immediate line removal
  4. Don't forget that amino acids increase osmolarity - dextrose/amino acid solutions without lipids have shorter peripheral catheter survival times 7
  5. Don't use peripheral lines for prolonged therapy - if >6 days anticipated, consider midline catheters; if >2 weeks, use central access 2

The evidence strongly supports that low-concentration dextrose solutions (≤10%) can be safely administered peripherally with appropriate monitoring, while higher concentrations require central venous access to prevent serious complications.

Related Questions

How many grams of carbohydrate are delivered over 12 hours when D5 (5% dextrose) is infused at 75 mL per hour?
How many milligrams of dextrose are present in a 50 mL bag of D5W (5 % dextrose) or D10W (10 % dextrose)?
Is it appropriate to administer 5% dextrose in 0.9% saline (dextrose normal saline) to a pregnant woman?
For continuous ambulatory peritoneal dialysis (CAPD), should a 2.5% dextrose solution with a 2000 mL volume be used for each exchange?
Is an infusion rate of 17.25 mL per hour of D10W (10% dextrose in water) appropriate for a 4‑year‑old child weighing 11.5 kg?
How do I quantify hypoxic burden in obstructive sleep apnea and what cardiovascular and mortality risks are associated with a high hypoxic burden?
In a 30‑year‑old woman with known bronchial asthma who presents with severe respiratory distress, cyanosis, tachycardia, hypoxemia, hypercapnia and respiratory acidosis after paint‑fume inhalation, what is the best immediate management action?
Does dry konjac rice affect blood glucose levels?
How do rehydrated (cooked) konjac rice and dry konjac rice differ in fiber density, net carbohydrate content, glycemic impact, and recommended usage for diabetic patients?
What is the safest immediate management for a conscious patient with chronic obstructive pulmonary disease presenting with dyspnea and an oxygen saturation of 70%: endotracheal intubation or a non‑rebreathing oxygen mask?
What is the incidence of febrile neutropenia in patients treated with pembrolizumab (Keytruda) monotherapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.